Dr. Reddy's Laboratories Limited
HealthcareNYSE:RDY · New York Stock Exchange
-$0.03 today
Vol 1.01M · Avg 2.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-15.39%
Period High
$15.72
Period Low
$12.46
Latest
$13.30
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$32.75B
Viatris Inc.
NASDAQ:VTRS
$19.10B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$16.15B
Solventum Corporation
NYSE:SOLV
$13.54B
Exelixis, Inc.
NASDAQ:EXEL
$13.38B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.07B
Revvity, Inc.
NYSE:RVTY
$11.11B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.84B
Encompass Health Corporation
NYSE:EHC
$10.11B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.69B
What is the latest RDY filing?
The latest filing shown is 6-K dated Jun 10, 2026.
How many recent filings does RDY have?
Intrinsic Alpha currently shows 20 recent filings for RDY.
Explore More
Continue the stock analysis
Jump to another research area for this company.